Nordea Investment Management AB Has $128.99 Million Stake in Amdocs Limited $DOX

Key Points

• Nordea Investment Management reduced its stake in Amdocs by 10.9% in Q4 to 1,604,770 shares valued at $128.99 million, representing about 1.49% of the company.
• In the most recent quarter (reported Feb. 3) Amdocs beat earnings with $1.81 EPS vs. $1.75 expected and revenue of $1.16 billion (up 4.1% year-over-year), and provided Q2 2026 and FY2026 EPS guidance.
• Amdocs raised its quarterly dividend to $0.569 (from $0.53), equivalent to a $2.28 annualized payout and a ~3.5% yield.

Nordea Investment Management AB reduced its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 10.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,604,770 shares of the technology company's stock after selling 196,716 shares during the quarter. Nordea Investment Management AB owned 1.49% of Amdocs worth $128,991,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of DOX. Harbor Capital Advisors Inc. bought a new stake in Amdocs during the 3rd quarter worth approximately $26,000. Root Financial Partners LLC bought a new position in Amdocs in the third quarter valued at approximately $26,000. WealthCollab LLC boosted its holdings in shares of Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company's stock valued at $29,000 after buying an additional 173 shares during the period. Atlantic Union Bankshares Corp acquired a new position in shares of Amdocs in the third quarter valued at approximately $37,000. Finally, Abich Financial Wealth Management LLC bought a new stake in shares of Amdocs during the third quarter worth $39,000. Institutional investors and hedge funds own 92.02% of the company's stock.

Amdocs Stock Performance

Shares of DOX opened at $64.83 on Monday. The stock has a market capitalization of $7.00 billion, a price-to-earnings ratio of 12.54, a PEG ratio of 1.15 and a beta of 0.42. Amdocs Limited has a 12 month low of $63.53 and a 12 month high of $95.41. The firm has a fifty day simple moving average of $73.35 and a 200 day simple moving average of $78.44. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The firm had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same period in the previous year, the business earned $1.66 EPS. The company's revenue was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Research analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.569 per share. The ex-dividend date is Tuesday, March 31st. This is a boost from Amdocs's previous quarterly dividend of $0.53. This represents a $2.28 annualized dividend and a yield of 3.5%. Amdocs's dividend payout ratio is currently 43.91%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on DOX. Weiss Ratings restated a "hold (c)" rating on shares of Amdocs in a report on Tuesday, January 27th. Stifel Nicolaus dropped their price target on Amdocs from $97.00 to $88.00 and set a "buy" rating on the stock in a research note on Wednesday, February 4th. Barclays cut their price target on Amdocs from $111.00 to $92.00 and set an "overweight" rating on the stock in a report on Wednesday, February 4th. Finally, Wall Street Zen cut Amdocs from a "buy" rating to a "hold" rating in a research report on Saturday. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $92.33.

About Amdocs

Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.